Recently Viewed
Clear All$14.51
$0.15
(1.04%)
As on 01-Apr-2026 16:00EDT
Today’s Range
52 Week Range
Liquidity
Market cap
$863 Mln
Revenue (TTM)
$-- Mln
Net Profit (TTM)
$-- Mln
ROE
0 %
ROCE
-- %
P/E Ratio
5.4
P/B Ratio
0.8
Industry P/E
--
EV/EBITDA
0
Div. Yield
0 %
Debt to Equity
0
Book Value
$58
EPS
$1.8
Face value
--
Shares outstanding
62,501,404
CFO
$--
EBITDA
$--
Net Profit
$--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
| -3.6 | -3.5 | -3.6 | -2.6 | -4.6 | -11.2 | -- |
|
BSE Sensex*
| -13.5 | -9.9 | -14.0 | -3.7 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
| 4.5 | -1.7 | -5.1 | -39.2 | -6.3 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
|
14.5 | 862.5 | 24.1 | 23.5 | -- | 3.5 | 5.4 | 0.8 |
| 14.4 | 1,453.2 | 225.0 | 222.0 | -- | 13.4 | 6.5 | 0.9 | |
| 6.9 | 1,719.5 | 40.7 | 35.7 | -- | 1.9 | 9.1 | 0.5 | |
| 22.9 | 1,469.1 | 82.5 | 54.5 | 170.8 | 3.5 | 24.6 | 0.9 | |
| 22.6 | 1,458.1 | 266.0 | 314.4 | -- | 20.3 | 4.6 | 0.9 | |
| 10.1 | 2,786.7 | 1,171.0 | 11.0 | 56.7 | 0.2 | 248.8 | 0.5 | |
| 13.8 | 2,418.5 | -42.2 | -46.9 | 60.8 | -1.9 | -- | 1.0 | |
| 13.2 | 1,772.5 | 30.7 | 30.6 | -- | 2.1 | 6.9 | 1.0 | |
| 17.3 | 1,611.5 | 101.9 | 174.1 | -- | 8 | 9.3 | 0.7 | |
| 32.0 | 1,654.2 | 204.6 | 254.3 | -- | 13.1 | 6.3 | 0.9 |
Address: 50 Hudson Yards, New York, NY, United States, 10001
Portfolio Mang.
Mr. Jeffrey Gene Lee
Portfolio Manager
Dr. Xiang Liu Ph.D.
Headquarters
New York, NY
Website
--
Our rating system has guided millions of investors in the past 20 years.
The share price of BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) is $14.51 (NYSE) as of 01-Apr-2026 16:00 EDT. BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) has given a return of -4.6% in the last 3 years.
The P/E ratio of BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) is 5.43 times as on 31-Mar-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
8.14
|
0.25
|
|
2023
|
10.21
|
0.35
|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
The 52-week high and low of BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) are Rs 15.80 and Rs 12.58 as of 02-Apr-2026.
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) has a market capitalisation of $ 863 Mln as on 31-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.